Login


TI Ref No : 529583307
Description : Acquisition Of Vedolizumab Sc 168mg0.68ml Solution For Injection Can From Lab. Takeda For Ulsasi For The Year 2026 Contract Date: 26-01-2026 Contract Price: €64,370.00 Deadline: 364 Days Place Of Execution: Portugal, Lisbon, Amadora.acquisition Of Vedoliz
Date : 2026-02-28
Deadline : 2026-04-26
Document Type : Contracts
View Details
Whats app